| Primary |
| Product Used For Unknown Indication |
55.6% |
| Hypertension |
22.2% |
| Blood Pressure |
11.1% |
| Hyperphosphataemia |
11.1% |
|
| Inappropriate Schedule Of Drug Administration |
16.7% |
| Nodal Arrhythmia |
16.7% |
| Renal Artery Stenosis |
16.7% |
| Renal Failure |
16.7% |
| Supraventricular Extrasystoles |
16.7% |
| Vomiting |
16.7% |
|
| Secondary |
| Hypertension |
18.5% |
| Product Used For Unknown Indication |
15.0% |
| Essential Hypertension |
14.0% |
| Drug Use For Unknown Indication |
7.1% |
| Drug Exposure During Pregnancy |
4.5% |
| Epilepsy |
4.5% |
| Neuropsychiatric Lupus |
4.2% |
| Pre-eclampsia |
4.2% |
| Hypotension |
3.4% |
| Diabetes Mellitus |
3.2% |
| Complication Of Pregnancy |
2.6% |
| Hypothyroidism |
2.6% |
| Osteoporosis |
2.4% |
| Type 2 Diabetes Mellitus |
2.4% |
| Depression |
2.1% |
| Prophylaxis |
2.1% |
| Systemic Lupus Erythematosus |
2.1% |
| Prostatitis |
1.8% |
| Cardiac Failure |
1.6% |
| Gastritis |
1.6% |
|
| Premature Baby |
18.2% |
| Thrombocytopenia |
7.8% |
| Bone Marrow Failure |
6.5% |
| Bone Marrow Toxicity |
5.2% |
| Foetal Growth Restriction |
5.2% |
| Renal Failure |
5.2% |
| Respiratory Distress |
5.2% |
| Sudden Death |
5.2% |
| Intra-uterine Death |
3.9% |
| Lactic Acidosis |
3.9% |
| Leukocytoclastic Vasculitis |
3.9% |
| Pierre Robin Syndrome |
3.9% |
| Premature Labour |
3.9% |
| Tinnitus |
3.9% |
| Tracheomalacia |
3.9% |
| Tremor |
3.9% |
| Drug Exposure Via Breast Milk |
2.6% |
| Hypertension |
2.6% |
| Maternal Drugs Affecting Foetus |
2.6% |
| Maternal Exposure Timing Unspecified |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.1% |
| Drug Use For Unknown Indication |
22.2% |
| Hypertension |
17.2% |
| Pain |
3.7% |
| Diabetes Mellitus |
2.9% |
| Depression |
2.6% |
| Nuclear Magnetic Resonance Imaging |
2.6% |
| Rheumatoid Arthritis |
1.9% |
| Angiogram |
1.6% |
| Atrial Fibrillation |
1.6% |
| Insomnia |
1.4% |
| Prophylaxis |
1.4% |
| Drug Exposure During Pregnancy |
1.3% |
| Multiple Sclerosis |
1.3% |
| Renal Transplant |
1.3% |
| Foetal Exposure During Pregnancy |
1.1% |
| Sepsis |
1.1% |
| Hiv Infection |
0.9% |
| Multiple Myeloma |
0.9% |
| Nausea |
0.9% |
|
| Premature Baby |
17.8% |
| Weight Decreased |
7.8% |
| Dermatitis Bullous |
5.6% |
| Myocardial Infarction |
5.6% |
| Umbilical Cord Abnormality |
5.6% |
| Blood Pressure Increased |
4.4% |
| Colon Cancer Stage Iii |
4.4% |
| Intra-uterine Death |
4.4% |
| Rash |
4.4% |
| Tongue Neoplasm Malignant Stage Unspecified |
4.4% |
| Toxic Skin Eruption |
4.4% |
| Withdrawal Syndrome |
4.4% |
| Hypertension |
3.3% |
| Oedema Peripheral |
3.3% |
| Paraesthesia |
3.3% |
| Pre-eclampsia |
3.3% |
| Pulmonary Arterial Hypertension |
3.3% |
| Transient Ischaemic Attack |
3.3% |
| Unresponsive To Stimuli |
3.3% |
| Venous Stenosis |
3.3% |
|
